Showing 1 - 7 results of 7 for search 'Accountancy', query time: 0.17s Refine Results
  1. 1
    by A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov
    Published 2018-06-01
    ... on onabotulinumtoxinА (BoNTA-Ona and abobotulinumtoxinА (BoNTA-Abo) accounting for properties of ­exible administration...
    Get full text
    Article
  2. 2
    by D. Yu. Belousov, A. E. Cheberda
    Published 2018-05-01
    ... standards of diabetic neuropathy treatment. The model accounted for existing data regarding long-term...
    Get full text
    Article
  3. 3
    by A. E. Cheberda, D. Yu. Belousov, M. M. Shishkin
    Published 2018-05-01
    ... as efficacy criterion. Time horizon of PHe analysis was set at 3 years. Costs were accounted based on existing...
    Get full text
    Article
  4. 4
    by A. E. Cheberda, D. Yu. Belousov, M. M. Shishkin
    Published 2018-05-01
    ... as efficacy criterion. Time horizon of PHe analysis was set at 3 years. Costs were accounted based on existing...
    Get full text
    Article
  5. 5
    by A. E. Cheberda, D. Yu. Belousov, A. N. Bogolepova
    Published 2018-05-01
    ... were accounted. The source of data on the clinical effectiveness was taken from randomized controlled...
    Get full text
    Article
  6. 6
    by A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    ... were also accounted for. Cost-effectiveness analysis, Cost-minimization analysis, Budget impact...
    Get full text
    Article
  7. 7
    by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    ... compared to adalimumab (estimated per 100 000 per 2 years of Russian population (246 patients), accounted...
    Get full text
    Article